ACB $9.858 (-1.62%)

ACNNF $0.111 (14.88%)

AERO $4.530 (0.78%)

AGEEF $0.100 (-2.25%)

ALEAF $0.435 (-3.72%)

AMMJ $0.111 (2.73%)

APHA $4.450 (-3.89%)

ARNA $62.810 (-1.98%)

ATT:CNX $0.080 (0%)

ATTBF $0.007 (-2.04%)

AUSA:CNX $0.160 (-3.03%)

AUSAF $0.126 (0.54%)

AVXL $3.925 (-0.63%)

BAMM:CNX $0.325 (-4.41%)

BBM:CNX $0.055 (0%)

BBRRF $0.045 (0%)

BE:CNX $0.005 (0%)

BIO:CNX $0.075 (0%)

BLEVF $0.004 (11.11%)

BLIS:CNX $0.315 (0%)

BLO:CNX $0.490 (2.08%)

BLOZF $0.361 (0.06%)

BUDZ $0.255 (-1.85%)

BXNG $0.520 (-1.89%)

CADMF $0.618 (-11.14%)

CALI:CNX $0.110 (0%)

CANN $0.400 (0.63%)

CARA $17.430 (1.22%)

CBII:CNX $0.115 (-4.17%)

CBIIF $0.094 (-1.3%)

CBWTF $0.179 (-0.56%)

CGC $17.010 (0.35%)

CGRW $0.090 (9.09%)

CHOO:CNX $0.110 (0%)

CHOOF $0.079 (-4.83%)

CNBX $0.195 (-0.51%)

CNGGF $0.310 (0%)

CODI $17.720 (1.32%)

CPMD $1.850 (-13.95%)

CRBP $6.960 (1.31%)

CRON $5.550 (-4.31%)

CROP:CNX $0.015 (0%)

CRTPF $1.510 (-6.79%)

CRXPF $0.025 (-16.67%)

CSI:CNX $0.920 (0%)

CURR $1.660 (12.16%)

CVSI $0.666 (-4.69%)

DIGP $0.030 (-20.63%)

DXBRF $0.140 (0%)

EAPH $0.001 (57.14%)

EAT:CNX $0.025 (0%)

EEVVF $0.055 (0%)

EMHTF $0.136 (-1.02%)

EPWCF $0.038 (-8.64%)

EVIO $0.018 (-7.89%)

FFRMF $0.030 (7.14%)

FFT:CNX $0.040 (0%)

FNNZF $0.087 (24.39%)

GGTTF $0.085 (-6.66%)

GLDFF $0.017 (-11.46%)

GLH:CNX $0.020 (-20%)

GNBT $0.420 (-4.47%)

GRIN:CNX $0.120 (0%)

GRWG $8.610 (-7.12%)

GSTR:CNX $0.085 (-5.56%)

GTBIF $14.470 (-3.47%)

GTII:CNX $19.690 (2.29%)

GWPH $109.800 (-3.64%)

HEXO $0.708 (0.45%)

HHPHF $0.003 (4%)

HLSPY $0.440 (0%)

HMLSF $5.080 (-3.04%)

HMPPF $0.498 (0%)

HRVOF $0.053 (-18.34%)

HSTRF $0.104 (0.97%)

HUGE:CNX $3.830 (-1.29%)

IAN:CNX $0.305 (0%)

IGC $1.570 (145.54%)

IGXT $0.191 (-7.78%)

IIPR $115.700 (1.54%)

IMLFF $5.086 (-2.21%)

INQD $0.005 (-13.64%)

IONC:CNX $0.015 (0%)

IONKF $0.020 (17.65%)

ISOL:CNX $0.045 (0%)

ISOLF $0.035 (-10.94%)

ITHUF $0.063 (-1.88%)

IVITF $0.013 (-16.67%)

JWCAF $0.025 (706.45%)

KALTF $0.001 (0%)

KBEV:CNX $0.065 (-13.33%)

KBEVF $0.050 (4.17%)

KHRNF $0.385 (0.03%)

KSHB $0.682 (-0.41%)

LHS:CNX $0.520 (6.12%)

LHSIF $0.374 (1.56%)

LOVE:CNX $0.095 (0%)

LXRP $0.354 (-3.23%)

LXX:CNX $0.480 (4.35%)

MCIG $0.028 (0%)

MEDIF $0.781 (0.85%)

MGWFF $0.055 (-4.35%)

MICWF $0.059 (-0.55%)

MJ:CNX $0.035 (0%)

MJNA $0.015 (3.52%)

MNTR $0.082 (1.23%)

MRRCF $0.004 (-5.26%)

MWM:CNX $0.065 (0%)

MYM:CNX $0.065 (-7.14%)

MYMMF $0.058 (3.78%)

NCNNF $0.137 (4.2%)

NDVAF $0.214 (-0.26%)

NGW:CNX $0.225 (-2.17%)

NRXCF $0.096 (-7.83%)

NSPDF $0.051 (-9.11%)

NTEC $0.369 (-8.71%)

NVTQF $0.451 (0%)

NWKRF $0.424 (0%)

NXGWF $0.173 (-3.89%)

NXTTF $0.215 (-2.14%)

OH:CNX $5.330 (0%)

ORHOF $4.050 (0%)

OWCP $0.009 (-3.28%)

PHCG $0.480 (0%)

PHVAF $0.038 (-7.54%)

PILL:CNX $0.700 (-1.41%)

PKG:CNX $0.075 (-6.25%)

PLPRF $0.460 (-2.11%)

PLUS:CNX $0.610 (0%)

PMCB $0.015 (0%)

PNPL $0.110 (0%)

POTN $0.014 (-3.07%)

PRCNF $0.008 (-17.35%)

PTNYF $0.060 (-5.94%)

QCA:CNX $0.110 (0%)

RDDTF $0.106 (2.12%)

RLLVF $0.028 (0%)

RMHB $0.038 (7.97%)

RQB:CNX $0.005 (0%)

RQHTF $0.215 (4.88%)

RVVQF $0.009 (-18.18%)

SLNG:CNX $0.135 (-3.57%)

SMG $159.380 (3.07%)

SNN:CNX $0.155 (0%)

SNNVF $0.120 (-1.64%)

SOL:CNX $0.400 (-9.09%)

SOLCF $0.322 (3.81%)

SPLIF $0.016 (-17.95%)

SPRWF $0.163 (-1.27%)

SRNA $0.032 (-32.13%)

STEM:CNX $0.470 (0%)

STMH $0.355 (-11.25%)

SUN:CNX $0.170 (25.93%)

TBPMF $0.150 (-4.64%)

TCAN:CNX $1.200 (-0.83%)

TCNAF $0.920 (0.22%)

TER:CNX $4.830 (0.63%)

TGEN $0.690 (-17.71%)

TGIF:CNX $0.065 (0%)

TGIFF $0.050 (-0.99%)

THC:CNX $0.180 (0%)

THCBF $0.141 (5.85%)

TLRY $6.930 (-13.05%)

TOKI:CNX $0.030 (0%)

TRLFF $0.031 (5.85%)

TRSSF $3.620 (-3.49%)

TRTC $0.083 (-2.12%)

TURV $0.129 (-0.46%)

VBIO $0.190 (-2.56%)

VIDA:CNX $0.055 (10%)

VIN:CNX $0.025 (0%)

VPRB $0.008 (-10.26%)

VRNDF $0.496 (2.78%)

VRT:CNX $0.190 (5.56%)

VRTHF $0.118 (-1.01%)

VVCIF $0.184 (-3.01%)

WAYL:CNX $0.740 (0%)

WDDMF $0.287 (7.45%)

WLDFF $0.104 (0%)

XXII $0.704 (-0.94%)

ZDPY $0.170 (-20.91%)

ZYNE $4.070 (-4.01%)

Technical420 Site Search

Returned 38 result(s).

3 Cannabis Stocks We Were Right On From The Beginning

During the last decade, the legal cannabis industry has made incredible advancements as countries across the globe have legalized or decriminalized the plant. In the US, several of the largest states have legalized cannabis while it remains illegal at the federal level and this has made the investing process more…

GW Pharmaceuticals plc Reports Second Quarter 2020 Financial Results and Operational Progress

GW Pharmaceuticals plc (Nasdaq: GWPH), a world leader in the science, development, and commercialization of cannabinoid prescription medicines, today announced financial results and operating progress for the second quarter ended June 30, 2020. “We were pleased with the strength of U.S. Epidiolex sales in the second quarter in spite of…

GW Pharmaceuticals plc to Report Financial Results and Operational Progress for the Second Quarter

GW Pharmaceuticals plc (Nasdaq:GWPH), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, will announce on August 6th, 2020 its financial results and operational progress for the second quarter ending June 30th, 2020. GW will also host a conference call the same…

5 Cannabis Stocks That Should Outperform Their Peers In The Back Half Of 2020

2020 has not lived up to expectations for the global cannabis industry and much of the blame can be attributed to COVID-19. Going forward, we believe that the industry is poised to record growth as lockdown orders start to get lifted in provinces across Canada and in the European Union…

GW Pharmaceuticals Presents Nabiximols U.S. Development and Commercial Strategy

GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), a world leader in the science, development, and commercialization of cannabinoid prescription medicines, today announces the Company’s strategy for bringing its pipeline product nabiximols to the U.S. market. This strategy includes multiple opportunities for the submission of an initial…

GW Pharmaceuticals submits Type II Variation Application to the European Medicines Agency (EMA) to expand the use of EPIDYOLEX®, (cannabidiol) oral solution, for the treatment of seizures associated with Tuberous Sclerosis Complex (TSC)

GW Pharmaceuticals plc (Nasdaq: GWPH) (“GW”, “the Company” or “the Group”), a world leader in discovering, developing and commercialising cannabinoid prescription medicines, today announces the submission of a Type II Variation Application to the European Medicines Agency (EMA) seeking approval of EPIDYOLEX®, (cannabidiol) oral solution, for the treatment of seizures…

3 Major European Cannabis Markets Investors Need To Be Watching

During the last year, we have seen a significant shift in the cannabis sector to where the market is considerably more focused on the international opportunity. Although Canada remains a great opportunity, the market is saturated, and distribution is limited. For this reason, we have seen a significant increase in…

3 Cannabis Stocks That Could Benefit From Feeling The Bern In 2020

Following Bernie Sanders’ victory in New Hampshire, we have received an influx of questions on the cannabis companies that would benefit from him being elected president of the United States. Bernie Sanders has previously stated that he would support the legal cannabis industry and highlighted plans to legalize the plant…

GW Pharmaceuticals and Greenwich Biosciences Submit Supplemental New Drug Application to U.S. FDA for Epidiolex® (cannabidiol) for the Treatment of Tuberous Sclerosis Complex

GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, along with its U.S. subsidiary Greenwich Biosciences, Inc., announced today that it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug…

5 Cannabis Stocks That Could Capitalize On The Booming EU Cannabis Sector

During the last year, the cannabis sector has been in the middle of a major transition that has been centered around the expansion into new markets. The European Union (EU) has been a point of emphasis for these cannabis operators and we are favorably on this strategy for growth. When…

Older Posts »

Search Again